Considerations for post-operative radiotherapy to the hemithorax following extrapleural pneumonectomy in malignant pleural mesothelioma

Lung Cancer

Volumn 45, Issue SUPPL., 2004, Pages

  Senan, Suresh ^a   Van De Pol, Marjan ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Clinical target volume; Early stage malignant pleural mesothelioma; Extrapleural pneumonectomy; Intensity modulated radiotherapy; Post operative radiotherapy

Indexed keywords

CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CONFERENCE PAPER; EXTRAPLEURAL PNEUMONECTOMY; HUMAN; LUNG RESECTION; MALIGNANT MESOTHELIOMA; NETHERLANDS; PLEURA MESOTHELIOMA; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION INJURY; THORAX; TREATMENT PLANNING;

DOSE FRACTIONATION; HUMANS; MESOTHELIOMA; PATIENT SELECTION; PLEURAL NEOPLASMS; PNEUMONECTOMY; PRACTICE GUIDELINES; RADIOTHERAPY, ADJUVANT;

EID: 3142771890     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.04.019     Document Type: Conference Paper

References (13)

1. Rusch V.W., Piantadosi S., Holmes E.C. The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial. J. Thorac. Cardiovasc. Surg. 102:1991;1-9
2. Pass H.I., Kranda K., Temeck B.K., Feuerstein I., Steinberg S.M. Surgically debulked malignant pleural mesothelioma: results and prognostic factors. Ann. Surg. Oncol. 4:1997;215-222
3. Baldini E.H., Recht A., Strauss G.M., DeCamp M.M. Jr., Swanson S.J., Liptay M.J., et al. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann. Thorac. Surg. 63:1997;334-338
4. Rusch V.W., Rosenzweig K., Venkatraman E., Leon L., Raben A., Harrison L., et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J. Thorac. Cardiovasc. Surg. 122:2001;788-795
5. Yajnik S., Rosenzweig K.E., Mychalczak B., Krug L., Flores R., Hong L., et al. Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma. Int. J. Radiat. Oncol. Biol. Phys. 56:2003;1319-1326
6. Ahamad A., Stevens C.W., Smythe W.R., Vaporciyan A.A., Komaki R., Kelly J.F., et al. Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. Int. J. Radiat. Oncol. Biol. Phys. 55:2003;768-775
7. Vogelzang N.J., Rusthoven J.J., Symanowski J., Denham C., Kaukel E., Ruffie P., et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J. Clin. Oncol. 21:2003;2636-2644
8. Green M.R. Alimta (pemetrexed disodium): a multitargeted antifolate for the treatment of mesothelioma. Lung Cancer. 38:2002;s55-s57
9. Graham M.V., Purdy J.A., Emami B., Harms W., Bosch W., Lockett M.A., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int. J. Radiat. Oncol. Biol. Phys. 45:1999;323-329
10. Dawson L.A., Normolle D., Balter J.M., McGinn C.J., Lawrence T.S., Ten Haken R.K. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int. J. Radiat. Oncol. Biol. Phys. 53:2002;810-821
11. Burman C., Kutcher G.J., Emami B., Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int. J. Radiat. Oncol. Biol. Phys. 21:1991;123-135
12. Intensity Modulated Radiation Therapy Collaborative Working Group. Intensity-modulated radiotherapy: current status and issues of interest. Int J Radiat Oncol Biol Phys 2001;51:880-914.
13. Forster K.M., Smythe W.R., Starkschall G., Liao Z., Takanaka T., Kelly J.F., et al. Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation. Int. J. Radiat. Oncol. Biol. Phys. 55:2003;606-616